Baseline characteristics from evoke and evoke+: Two phase 3 randomized placebo‐controlled trials of semaglutide in participants with early‐stage symptomatic Alzheimer's disease

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Philip Scheltens, Alireza Atri, Howard H. Feldman, Henrik Zetterberg, Mary Sano, Peter Johannsen, Teresa León Colombo, Lars Bardtrum, Rose Jeppesen, Charlotte T. Hansen, Jeffrey L. Cummings
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Alzheimer's & Dementia: Translational Research & Clinical Interventions
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet